Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bravi D., Anderson J. J., Dagani F., Davis T. L., Ferrari R., Gillespie M., Chase T. N. Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Mov Disord. 1992;7(3):228–231. doi: 10.1002/mds.870070307. [DOI] [PubMed] [Google Scholar]
- Ichiki T., Tanaka M., Nishikimi M., Suzuki H., Ozawa T., Kobayashi M., Wada Y. Deficiency of subunits of Complex I and mitochondrial encephalomyopathy. Ann Neurol. 1988 Mar;23(3):287–294. doi: 10.1002/ana.410230312. [DOI] [PubMed] [Google Scholar]
- Mizuno Y., Saitoh T., Sone N. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion. Biochem Biophys Res Commun. 1987 Feb 27;143(1):294–299. doi: 10.1016/0006-291x(87)90664-4. [DOI] [PubMed] [Google Scholar]
- Nakagawa-Hattori Y., Yoshino H., Kondo T., Mizuno Y., Horai S. Is Parkinson's disease a mitochondrial disorder? J Neurol Sci. 1992 Jan;107(1):29–33. doi: 10.1016/0022-510x(92)90205-y. [DOI] [PubMed] [Google Scholar]
- Pavlakis S. G., Phillips P. C., DiMauro S., De Vivo D. C., Rowland L. P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984 Oct;16(4):481–488. doi: 10.1002/ana.410160409. [DOI] [PubMed] [Google Scholar]
- Przedborski S., Jackson-Lewis V., Muthane U., Jiang H., Ferreira M., Naini A. B., Fahn S. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Ann Neurol. 1993 Nov;34(5):715–723. doi: 10.1002/ana.410340515. [DOI] [PubMed] [Google Scholar]
- Schapira A. H. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal. Mov Disord. 1994 Mar;9(2):125–138. doi: 10.1002/mds.870090202. [DOI] [PubMed] [Google Scholar]